|
Dr. Neal Rosen, the last listed of the authors
He has been involved in breast cancer research for years and gave a talk on what "oncogene addiction" really means--many articles use the term incorrectly..
Much of his research has been on Heat Shock Protein inhibitors, some of which
may come on the market in the foreseeable future and seem to work well with herceptin for her2+ breast cancer.
|